Tamoxifen (TXF)

[Edit]

Nolvadex; Istubal; Valodex

Tamoxifen (TXF)
Tamoxifen is an antagonist of the estrogen receptor in breast tissue via its active metabolite, hydroxytamoxifen. In other tissues such as the endometrium, it behaves as an agonist, and thus may be characterized as a mixed agonist/antagonist. Tamoxifen is the usual endocrine therapy for hormone receptor-positive breast cancer in pre-menopausal women, and is also a standard in post-menopausal women although aromatase inhibitors are also frequently used in that setting.Some breast cancer cells require estrogen to grow. Estrogen binds to and activates the estrogen receptor in these cells. Tamoxifen is metabolized into compounds that also bind to the estrogen receptor but do not activate it. Because of this competitive antagonism, tamoxifen acts like a key broken off in the lock that prevents any other key from being inserted, preventing estrogen from binding to its receptor. Hence breast cancer cell growth is blocked.

Organism species: Pan-species (General)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Complete Antigen of Tamoxifen (TXF) Antigenic Transformation Customized Service Offer
Antibodies n/a Monoclonal Antibody to Tamoxifen (TXF) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Tamoxifen (TXF) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Tamoxifen (TXF) CLIA Kit Customized Service Offer
n/a ELISA Kit for Tamoxifen (TXF) ELISA Kit Customized Service Offer